SCHEMBL3073542

SCHEMBL3073542

Fc1cccc(C(c2ccncc2)c2cnc[nH]2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 7/20 0.49
IDO1 P14902 1/20 0.44
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
HRH3 Q9Y5N1 3/20 0.39
ADRA2A P08913 3/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
HRH1 P35367 1/20 0.39
HRH4 Q9H3N8 1/20 0.39
TAAR1 Q96RJ0 1/20 0.38
ADRA2B P18089 2/20 0.36
ADRA2C P18825 2/20 0.36
ADRA1D P25100 1/20 0.35
ADRA1A P35348 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1639415 0.91 CYP19A1 (0.55) CYP19A1IDO1ADRA2ATAAR1ADRA2B
SCHEMBL3071932 0.87 CYP19A1 (0.48) CYP19A1IDO1SLC6A2SLC6A4SLC6A3
SCHEMBL3065262 0.83 SLC6A2 (0.59) CYP19A1IDO1SLC6A2SLC6A4SLC6A3
SCHEMBL3051058 0.82 CYP19A1 (0.46) CYP19A1IDO1SLC6A2SLC6A4SLC6A3
SCHEMBL3062666 0.79 ADRA2A (0.40) CYP19A1SLC6A2SLC6A4SLC6A3HRH3
SCHEMBL2626807 0.78 ADRA2A (0.60) CYP19A1IDO1SLC6A2ADRA2ACYP1A2
SCHEMBL2626836 0.76 CYP19A1 (0.43) CYP19A1IDO1HRH3ADRA2AHRH4
SCHEMBL13089060 0.76 CYP19A1 (0.42) CYP19A1IDO1CYP11B1CYP11B2SLC6A2
SCHEMBL3055369 0.75 CYP19A1 (0.44) CYP19A1SLC6A2SLC6A4SLC6A3HRH3
SCHEMBL27911641 0.75 HRH3 (0.40) CYP19A1SLC6A2SLC6A4SLC6A3HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101743240-B ((phenyl) imidazolyl) methyl heteroaryl compounds ALLERGAN INC 2013-07-17 CN disclosed
EP-2155715-B1 ((PHENYL)IMIDAZOLYL)METHYLHETEROARYL COMPOUNDS ALLERGAN INC (US) 2013-03-13 EP disclosed
US-20100273814-A1 ((PHENYL)IMIDAZOLYL)METHYLHETEROARYL COMPOUNDS SINHA SANTOSH C 2010-10-28 US disclosed
CN-101743240-A ((phenyl) imidazolyl) methyl heteroaryl compounds ALLERGAN INC 2010-06-16 CN disclosed
EP-2155715-A1 ((PHENYL)IMIDAZOLYL)METHYLHETEROARYL COMPOUNDS ALLERGAN, INC. (US) 2010-02-24 EP disclosed
WO-2008141312-A1 ((PHENYL)IMIDAZOLYL)METHYLHETEROARYL COMPOUNDS ALLERGAN, INC. (US) 2008-11-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100273814-A1 ((PHENYL)IMIDAZOLYL)METHYLHETEROARYL COMPOUNDS CYP11B2, TPMT, COXFA4L2 CYP19A1 485/4885IDO1 1513/4885CYP11B1 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.